{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:11:38Z","timestamp":1792905098876,"version":"4.5.0"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bioorg.2022.105920","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T11:23:04Z","timestamp":1654082584000},"page":"105920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors"],"prefix":"10.1016","volume":"126","author":[{"given":"Amit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Siwach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2022.105920_b0005","doi-asserted-by":"crossref","unstructured":"F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin. 68 (2018) 394-424.","DOI":"10.3322\/caac.21492"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0010","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2022.105920_b0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bioorg.2018.01.021","article-title":"New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors","volume":"77","author":"Gul","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0020","first-page":"1549","article-title":"A carbonic anhydrase inhibitor as a potential modulator of cancer therapies","volume":"13","author":"Teicher","year":"1993","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2022.105920_b0025","first-page":"2877","article-title":"Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment","volume":"9","author":"Pastorek","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2022.105920_b0030","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1073\/pnas.95.13.7608","article-title":"Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers","volume":"95","author":"T\u00fcreci","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2022.105920_b0035","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.bmcl.2015.02.046","article-title":"The zinc coordination pattern in the \u03b7-carbonic anhydrase from Plasmodium falciparum is different from all other carbonic anhydrase genetic families","volume":"25","author":"De Simone","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"35","key":"10.1016\/j.bioorg.2022.105920_b0040","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1073\/pnas.1603112113","article-title":"Thylakoid luminal \u03b8-carbonic anhydrase critical for growth and photosynthesis in the marine diatom Phaeodactylum tricornutum","volume":"113","author":"Kikutani","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105920_b0045","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/s41396-019-0426-8","article-title":"A new widespread subclass of carbonic anhydrase in marine phytoplankton","volume":"13","author":"Jensen","year":"2019","journal-title":"The ISME journal"},{"key":"10.1016\/j.bioorg.2022.105920_b0050","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/14756366.2020.1755852","article-title":"Bacterial \u03b9-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii","volume":"35","author":"Del Prete","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105920_b0055","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0060","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/gast.1997.v112.pm9024293","article-title":"Carbonic anhydrase IX, MN\/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts","volume":"112","author":"Pastorekova","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bioorg.2022.105920_b0065","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0002-9440(10)64048-5","article-title":"Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast","volume":"158","author":"Wykoff","year":"2001","journal-title":"The American journal of pathology"},{"key":"10.1016\/j.bioorg.2022.105920_b0070","first-page":"5262","article-title":"Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density","volume":"61","author":"Beasley","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2022.105920_b0075","first-page":"6394","article-title":"Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix","volume":"61","author":"Loncaster","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2022.105920_b0080","first-page":"7992","article-title":"Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer","volume":"61","author":"Giatromanolaki","year":"2001","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105920_b0085","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.bjc.6600215","article-title":"The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer","volume":"86","author":"Turner","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2022.105920_b0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","article-title":"HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron","volume":"1","author":"Mandriota","year":"2002","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bioorg.2022.105920_b0095","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.bjc.6601727","article-title":"Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia","volume":"90","author":"Stessels","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105920_b0100","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2022.105920_b0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use, in","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol., Elsevier"},{"issue":"10","key":"10.1016\/j.bioorg.2022.105920_b0110","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","article-title":"Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018)","volume":"28","author":"Nocentini","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2022.105920_b0115","doi-asserted-by":"crossref","unstructured":"Y. Lou, P.C. McDonald, A. Oloumi, S. Chia, C. Ostlund, A. Ahmadi, A. Kyle, U. auf dem Keller, S. Leung, D. Huntsman, B. Clarke, B.W. Sutherland, D. Waterhouse, M. Bally, C. Roskelley, C.M. Overall, A. Minchinton, F. Pacchiano, F. Carta, A. Scozzafava, N. Touisni, J.-Y. Winum, C.T. Supuran, S. Dedhar, Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors, Cancer Res. 71 (2011) 3364-3376.","DOI":"10.1158\/0008-5472.CAN-10-4261"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105920_b0120","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2022.105920_b0125","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/jm200983e","article-title":"Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors","volume":"54","author":"Touisni","year":"2011","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105920_b0130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bioorg.2022.105920_b0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/metabo8010013","article-title":"Carbonic anhydrase IX (CAIX), cancer, and radiation responsiveness","volume":"8","author":"Ward","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2022.105920_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/metabo8020025","article-title":"Carbonic anhydrases and metabolism","volume":"8","author":"Supuran","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2022.105920_b0145","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0150","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1021\/jm9901879","article-title":"Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl\/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105920_b0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2022.105920_b0165","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"issue":"33","key":"10.1016\/j.bioorg.2022.105920_b0170","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1039\/C5CC01854D","article-title":"X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors","volume":"51","author":"Ivanova","year":"2015","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105920_b0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105920_b0180","first-page":"1314","article-title":"Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases, ACS Med","volume":"8","author":"Nocentini","year":"2017","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116140","article-title":"Developments of small molecules as inhibitors for carbonic anhydrase isoforms","volume":"39","author":"Buabeng","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/14756366.2017.1405263","article-title":"Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2, 4, 6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor","volume":"33","author":"Alterio","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105920_b0195","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jm501798g","article-title":"Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site","volume":"58","author":"Tanpure","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0200","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand\/Isoform Matching and Selectivity of Action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105920_b0205","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543776.2018.1523897","article-title":"Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105920_b0210","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1016\/j.ejmech.2011.07.011","article-title":"Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives","volume":"46","author":"Brzozowski","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105920_b0215","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1016\/j.ejmech.2010.05.011","article-title":"Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1, 4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII","volume":"45","author":"Brzozowski","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0220","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejmech.2012.08.006","article-title":"Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1, 4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII","volume":"56","author":"Brzozowski","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104204","article-title":"Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII","volume":"103","author":"Akocak","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0230","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/14756366.2017.1302441","article-title":"Synthesis of an acridine orange sulfonamide derivative with potent carbonic anhydrase IX inhibitory action","volume":"32","author":"Bragagni","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0235","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1016\/j.bmcl.2004.07.087","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1, 2, 4-triazine moieties","volume":"14","author":"Garaj","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0240","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.bmc.2011.04.005","article-title":"Sulfonamides incorporating 1, 3, 5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: solution and X-ray crystallographic studies","volume":"19","author":"Carta","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105920_b0245","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bmcl.2014.01.048","article-title":"Substituted benzene sulfonamides incorporating 1, 3, 5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII","volume":"24","author":"Saluja","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bioorg.2017.12.034","article-title":"Novel sulfonamide incorporating piperazine, aminoalcohol and 1, 3, 5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action","volume":"77","author":"Havr\u00e1nkov\u00e1","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0255","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bioorg.2018.08.005","article-title":"Novel sulfonamides incorporating 1, 3, 5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX","volume":"81","author":"Miku\u0161","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105920_b0260","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bmc.2019.03.001","article-title":"Discovery of new ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors","volume":"27","author":"Lolak","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105920_b0265","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.bmc.2014.03.029","article-title":"Pyrazolo [4, 3-e][1, 2, 4] triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity","volume":"22","author":"Mojzych","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2022.105920_b0270","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1016\/j.bmc.2015.04.011","article-title":"New pyrazolo [4, 3-e][1, 2, 4] triazine sulfonamides as carbonic anhydrase inhibitors","volume":"23","author":"Mojzych","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2022.105920_b0275","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bmc.2015.02.026","article-title":"New approaches to the synthesis of sildenafil analogues and their enzyme inhibitory activity","volume":"23","author":"Mojzych","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2022.105920_b0280","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1016\/j.bmc.2010.05.072","article-title":"Pteridine\u2013sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity","volume":"18","author":"Marques","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105920_b0285","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.bmc.2017.03.054","article-title":"Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII","volume":"25","author":"Bozdag","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0290","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14756366.2020.1742117","article-title":"S-substituted 2-mercaptoquinazolin-4 (3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors","volume":"35","author":"El-Azab","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2022.105920_b0295","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1021\/acs.jmedchem.8b00670","article-title":"4-substituted benzenesulfonamides incorporating bi\/tricyclic moieties act as potent and isoform-selective carbonic anhydrase ii\/ix inhibitors","volume":"61","author":"Salerno","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112019","article-title":"Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation","volume":"189","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0305","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0223-5234(98)80017-2","article-title":"Carbonic anhydrase inhibitors\u2014Part 53. Synthesis of substituted-pyridinium derivatives of aromatic sulfonamides: the first non-polymeric membrane-impermeable inhibitors with selectivity for isozyme IV","volume":"33","author":"Supuran","year":"1998","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0310","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14756360009040695","volume":"15","author":"Supuran","year":"2000","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/j.bioorg.2022.105920_b0315","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/jm990479+","article-title":"Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes","volume":"43","author":"Scozzafava","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0320","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bmcl.2003.12.029","article-title":"Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX","volume":"14","author":"Pastorekova","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0325","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.bmc.2012.10.029","article-title":"New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides","volume":"21","author":"Rogez-Florent","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0330","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2014.02.023","article-title":"4-Functionalized 1, 3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII","volume":"76","author":"Khloya","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2022.105920_b0335","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1016\/j.bmc.2014.10.018","article-title":"Sharma, 4-Functionalized 1, 3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII","volume":"22","author":"SitaRam","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0340","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bioorg.2019.03.052","article-title":"Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives","volume":"87","author":"Abdel-Aziz","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0345","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.3390\/ijms21072621","article-title":"Aryl-4, 5-dihydro-1H-pyrazole-1-carboxamide Derivatives Bearing a Sulfonamide Moiety Show Single-digit Nanomolar-to-Subnanomolar Inhibition Constants against the Tumor-associated Human Carbonic Anhydrases IX and XII","volume":"21","author":"Hargunani","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.bioorg.2022.105920_b0350","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.bmcl.2015.05.096","article-title":"Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII","volume":"25","author":"Khloya","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105920_b0355","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/ml500196t","article-title":"Carbonic anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry","volume":"5","author":"Pala","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0360","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","article-title":"Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations","volume":"59","author":"Nocentini","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0365","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bioorg.2019.01.002","article-title":"Synthesis of novel benzenesulfonamide bearing 1, 2, 3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors","volume":"85","author":"Sharma","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105920_b0370","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1021\/jm300427m","article-title":"Metallocene-based inhibitors of cancer-associated carbonic anhydrase enzymes IX and XII","volume":"55","author":"Salmon","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0375","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/acsmedchemlett.7b00205","article-title":"N-Acylbenzenesulfonamide dihydro-1, 3, 4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms","volume":"8","author":"Bianco","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0380","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1039\/C8CC09568J","article-title":"Polypharmacology of epacadostat: a potent and selective inhibitor of the tumor associated carbonic anhydrases IX and XII","volume":"55","author":"Angeli","year":"2019","journal-title":"Chem. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105920_b0385","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.bmc.2014.01.055","article-title":"Sharma, Benzenesulfonamide bearing 1, 2, 4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII","volume":"22","author":"SitaRam","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105920_b0390","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bmc.2016.12.047","article-title":"Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors","volume":"25","author":"Kumar","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2022.105920_b0395","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.bmcl.2010.06.082","article-title":"Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors","volume":"20","author":"Avvaru","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0400","doi-asserted-by":"crossref","first-page":"13064","DOI":"10.1021\/acs.jmedchem.0c01390","article-title":"Structural basis of nanomolar inhibition of tumor-associated carbonic anhydrase IX: X-ray crystallographic and inhibition study of lipophilic inhibitors with acetazolamide backbone","volume":"63","author":"Andring","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0405","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/14756366.2017.1367775","article-title":"Synthesis and biological evaluation of benzenesulphonamide-bearing 1, 4, 5-trisubstituted-1, 2, 3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity","volume":"32","author":"Kumar","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0410","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejmech.2018.06.021","article-title":"Design and synthesis of novel benzenesulfonamide containing 1, 2, 3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors","volume":"155","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0415","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.03.030","article-title":"Synthesis of novel 4-functionalized 1, 5-diaryl-1, 2, 3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors","volume":"150","author":"Vats","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111698","article-title":"Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors","volume":"183","author":"Vats","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112219","article-title":"Tail approach synthesis of novel benzenesulfonamides incorporating 1, 3, 4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes","volume":"193","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0430","doi-asserted-by":"crossref","unstructured":"M.A. Ilies, B. Masereel, S. Rolin, A. Scozzafava, G. C\u00e2mpeanu, V. C\u0131\u0302mpeanu, C.T. Supuran, Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity, Bioorg. Med. Chem. 12 (2004) 2717-2726.","DOI":"10.1016\/j.bmc.2004.03.008"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0435","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/14756366.2016.1235042","article-title":"Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors","volume":"32","author":"Melis","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105920_b0440","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.bmc.2016.02.036","article-title":"Isatin analogs as novel inhibitors of Candida spp. \u03b2-carbonic anhydrase enzymes","volume":"24","author":"Akdemir","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105920_b0445","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3109\/14756366.2016.1149479","article-title":"Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase","volume":"31","author":"Ozgun","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0450","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejmech.2016.06.034","article-title":"3-Hydrazinoindolin-2-one derivatives: chemical classification and investigation of their targets as anticancer agents","volume":"122","author":"Ibrahim","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0455","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4172\/2161-0444.1000179","article-title":"Isatins: a diversity orientated biological profile","volume":"4","author":"Kidwai","year":"2014","journal-title":"Med. Chem"},{"key":"10.1016\/j.bioorg.2022.105920_b0460","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40265-014-0335-0","article-title":"Nintedanib: first global approval","volume":"75","author":"McCormack","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2022.105920_b0465","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1158\/1078-0432.CCR-06-2328","article-title":"Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma","volume":"13","author":"Goodman","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.bioorg.2022.105920_b0470","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1039\/C5OB00688K","article-title":"Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"13","author":"G\u00fczel-Akdemir","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2022.105920_b0475","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1016\/j.bmc.2017.05.029","article-title":"Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases","volume":"25","author":"Karal\u0131","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0480","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2016.01.030","article-title":"Amido\/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar\/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII","volume":"110","author":"Eldehna","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0485","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2018.10.068","article-title":"Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents","volume":"162","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0490","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","article-title":"Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies","volume":"139","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0495","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bioorg.2018.09.007","article-title":"Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer","volume":"81","author":"Eldehna","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0500","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejmech.2015.09.021","article-title":"Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII","volume":"103","author":"Ibrahim","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111768","article-title":"3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights","volume":"184","author":"Abo-Ashour","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103635","article-title":"Synthesis of some N-aroyl-2-oxindole benzenesulfonamide conjugates with carbonic anhydrase inhibitory activity","volume":"96","author":"George","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"40","key":"10.1016\/j.bioorg.2022.105920_b0515","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1002\/anie.200701189","article-title":"Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste","volume":"46","author":"K\u00f6hler","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2022.105920_b0520","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1021\/acs.jmedchem.7b01470","article-title":"\u201cSeriously Sweet\u201d: acesulfame K exhibits selective inhibition using alternative binding modes in carbonic anhydrase isoforms","volume":"61","author":"Murray","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0525","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bmc.2014.12.030","article-title":"Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors","volume":"23","author":"Mahon","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0530","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/jm500255y","article-title":"Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes","volume":"57","author":"Moeker","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0535","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.carres.2019.03.001","article-title":"Synthesis of saccharin-glycoconjugates targeting carbonic anhydrase using a one-pot cyclization\/deprotection strategy","volume":"476","author":"Murray","year":"2019","journal-title":"Carbohydr. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105920_b0540","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.bmc.2014.01.056","article-title":"Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII","volume":"22","author":"D\u2019Ascenzio","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0545","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejmech.2014.07.014","article-title":"Cyclic tertiary sulfamates: selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N-and O-substituted acesulfame derivatives","volume":"84","author":"De Monte","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105920_b0550","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bmc.2016.01.038","article-title":"A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms","volume":"24","author":"Carradori","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2022.105920_b0555","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/j.bmc.2017.04.007","article-title":"N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII","volume":"25","author":"Ivanova","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0560","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14756366.2016.1235040","article-title":"Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms","volume":"32","author":"D\u2019Ascenzio","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105920_b0565","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1021\/acs.jmedchem.9b01434","article-title":"1, 3-dipolar cycloaddition, HPLC enantioseparation, and docking studies of saccharin\/isoxazole and saccharin\/isoxazoline derivatives as selective carbonic anhydrase IX and XII inhibitors","volume":"63","author":"D\u2019Ascenzio","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0570","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1080\/14756366.2020.1828401","article-title":"Novel insights on saccharin-and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluation","volume":"35","author":"Guglielmi","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105920_b0575","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/med.20141","article-title":"Therapeutic applications of glycosidic carbonic anhydrase inhibitors","volume":"29","author":"Winum","year":"2009","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2022.105920_b0580","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.bmc.2012.10.043","article-title":"Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer","volume":"21","author":"Winum","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2022.105920_b0585","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1016\/j.bmcl.2011.08.066","article-title":"Synthesis of glycoconjugate carbonic anhydrase inhibitors by ruthenium-catalysed azide-alkyne 1, 3-dipolar cycloaddition","volume":"21","author":"Salmon","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"19","key":"10.1016\/j.bioorg.2022.105920_b0590","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/jm200892s","article-title":"Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors","volume":"54","author":"Morris","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0595","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1039\/c3cc42541j","article-title":"Thiol\u2013ene click chemistry for the synthesis of highly effective glycosyl sulfonamide carbonic anhydrase inhibitors","volume":"49","author":"Saada","year":"2013","journal-title":"Chem. Commun."},{"issue":"7","key":"10.1016\/j.bioorg.2022.105920_b0600","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.bmc.2012.01.052","article-title":"Design and synthesis of thiourea compounds that inhibit transmembrane anchored carbonic anhydrases","volume":"20","author":"Moeker","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2022.105920_b0605","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1021\/jm5012935","article-title":"Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates","volume":"57","author":"Moeker","year":"2014","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2022.105920_b0610","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1021\/acs.jmedchem.5b00845","article-title":"Mapping selective inhibition of the cancer-related carbonic anhydrase IX using structure\u2013activity relationships of glucosyl-based sulfamates","volume":"58","author":"Mahon","year":"2015","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105920_b0615","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/17425255.2020.1743679","article-title":"An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors","volume":"16","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"14","key":"10.1016\/j.bioorg.2022.105920_b0620","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.bmcl.2012.05.083","article-title":"Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines","volume":"22","author":"Winum","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0625","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0223-5234(98)80033-0","article-title":"Carbonic anhydrase inhibitors-Part 49: Synthesis of substituted ureido and thioureido derivatives of aromatic\/heterocyclic sulfonamides with increased affinities for isozyme I","volume":"33","author":"Supuran","year":"1998","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105920_b0630","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"Gieling","year":"2012","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105920_b0635","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmc.2017.03.027","article-title":"Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs","volume":"25","author":"Carta","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2022.105920_b0640","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1021\/acs.jmedchem.8b00770","article-title":"Discovery of 4-hydroxy-3-(3-(phenylureido) benzenesulfonamides as SLC-0111 analogues for the treatment of hypoxic tumors overexpressing carbonic anhydrase IX","volume":"61","author":"Bozdag","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0645","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bioorg.2018.11.014","article-title":"SLC-0111 enaminone analogs, 3\/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX","volume":"83","author":"Eldehna","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2022.105920_b0650","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.bmc.2015.05.013","article-title":"New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies","volume":"23","author":"Carradori","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0655","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1016\/j.bmc.2015.07.066","article-title":"Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies","volume":"23","author":"Mollica","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2022.105920_b0660","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1016\/j.bmcl.2011.07.090","article-title":"Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II","volume":"21","author":"Knaus","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0665","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bmc.2012.12.004","article-title":"Carbonic anhydrase inhibitors: Benzenesulfonamides incorporating cyanoacrylamide moieties are low nanomolar\/subnanomolar inhibitors of the tumor-associated isoforms IX and XII","volume":"21","author":"Alafeefy","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2022.105920_b0670","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bmcl.2014.02.030","article-title":"Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N, N-disubstituted sulfanilamides incorporating 4, 4, 4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2 (3H)-one\/thione moieties","volume":"24","author":"Congiu","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105920_b0675","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bmc.2016.01.020","article-title":"Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII","volume":"24","author":"Durgun","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105920_b0680","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1021\/acs.jmedchem.6b00492","article-title":"PEGylated bis-sulfonamide carbonic anhydrase inhibitors can efficiently control the growth of several carbonic anhydrase IX-expressing carcinomas","volume":"59","author":"Akocak","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.04.016","article-title":"Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform","volume":"152","author":"Ibrahim","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0690","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bioorg.2018.08.032","article-title":"Synthesis of novel dipeptide sulfonamide conjugates with effective carbonic anhydrase I, II, IX, and XII inhibitory properties","volume":"81","author":"Bu\u011fday","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0695","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.3390\/ijms20102484","article-title":"Novel diamide-based benzenesulfonamides as selective carbonic anhydrase IX inhibitors endowed with antitumor activity: synthesis, biological evaluation and in silico insights","volume":"20","author":"Abdelrahman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105920_b0700","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/acsmedchemlett.7b00387","article-title":"Synthesis of novel selenides bearing benzenesulfonamide moieties as carbonic anhydrase I, II, IV, VII, and IX inhibitors","volume":"8","author":"Angeli","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0705","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/ijms17071150","article-title":"Non-classical inhibition of carbonic anhydrase","volume":"17","author":"Lomelino","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.bioorg.2022.105920_b0710","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.bmcl.2014.09.076","article-title":"Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds","volume":"24","author":"Abdel-Aziz","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0715","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/molecules23010017","article-title":"Potent and selective carboxylic acid inhibitors of tumor-associated carbonic anhydrases IX and XII","volume":"23","author":"Cau","year":"2018","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bioorg.2022.105920_b0720","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/acsmedchemlett.9b00023","article-title":"\u03b1, \u03b3-Diketocarboxylic Acids and Their Esters Act as Carbonic Anhydrase IX and XII Selective Inhibitors","volume":"10","author":"Nocentini","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2022.105920_b0725","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2022.105920_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103739","article-title":"Design, synthesis and biological evaluation of coumarin linked 1, 2, 4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors","volume":"98","author":"Thacker","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0735","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2022.105920_b0740","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1016\/j.bmcl.2010.10.094","article-title":"7, 8-Disubstituted-but not 6, 7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar\/subnanomolar range","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"15","key":"10.1016\/j.bioorg.2022.105920_b0745","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.bmcl.2010.06.040","article-title":"Coumarins incorporating hydroxy-and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"21","key":"10.1016\/j.bioorg.2022.105920_b0750","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1016\/j.bmc.2015.09.041","article-title":"Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII","volume":"23","author":"Nocentini","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105920_b0755","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bmc.2016.11.039","article-title":"Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity","volume":"25","author":"Bozdag","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0760","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1080\/14756366.2017.1354857","article-title":"Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors","volume":"32","author":"Zengin Kurt","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0765","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bioorg.2019.03.003","article-title":"Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma","volume":"87","author":"Kurt","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0770","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejmech.2017.11.061","article-title":"Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases","volume":"143","author":"De Luca","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0775","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/molecules23010153","article-title":"Novel 6-and 7-substituted coumarins with inhibitory action against lipoxygenase and tumor-associated carbonic anhydrase IX","volume":"23","author":"Peperidou","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2022.105920_b0780","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bioorg.2019.02.004","article-title":"Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors","volume":"86","author":"Thacker","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0785","doi-asserted-by":"crossref","unstructured":"A. Petreni, A. Bonardi, C. Lomelino, S.M. Osman, Z.A. ALOthman, W.M. Eldehna, R. El-Haggar, R. McKenna, A. Nocentini, C.T. Supuran, Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells, Eur. J. Med. Chem. 190 (2020) 112112.","DOI":"10.1016\/j.ejmech.2020.112112"},{"key":"10.1016\/j.bioorg.2022.105920_b0790","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1021\/acs.jmedchem.0c00636","article-title":"Azidothymidine \u201cClicked\u201d into 1, 2, 3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors","volume":"63","author":"Berrino","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0795","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/jm301625s","article-title":"Sulfocoumarins (1, 2-benzoxathiine-2, 2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases","volume":"56","author":"Tars","year":"2013","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105920_b0800","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bmc.2014.01.043","article-title":"Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"22","author":"Grandane","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105920_b0805","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.bmcl.2014.01.076","article-title":"6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII","volume":"24","author":"Grandane","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0810","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1039\/C4OB02155J","article-title":"6-Substituted 1, 2-benzoxathiine-2, 2-dioxides are isoform-selective inhibitors of human carbonic anhydrases IX, XII and VA","volume":"13","author":"Tanc","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2022.105920_b0815","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bmc.2015.02.023","article-title":"Synthesis of 6-aryl-substituted sulfocoumarins and investigation of their carbonic anhydrase inhibitory action","volume":"23","author":"Grandane","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105920_b0820","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","article-title":"6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells","volume":"58","author":"Grandane","year":"2015","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105920_b0825","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3109\/14756366.2015.1115401","article-title":"7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII","volume":"31","author":"Nocentini","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0830","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acs.jmedchem.5b01720","article-title":"Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins","volume":"59","author":"Ferraroni","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0835","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejmech.2018.01.033","article-title":"Structural investigations on coumarins leading to chromeno [4, 3-c] pyrazol-4-ones and pyrano [4, 3-c] pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"146","author":"Bonardi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0840","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acsmedchemlett.8b00170","article-title":"Targeting tumor associated carbonic anhydrases IX and XII: highly isozyme selective coumarin and psoralen inhibitors","volume":"9","author":"Melis","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0845","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/14756366.2017.1316720","article-title":"3 H-1, 2-benzoxathiepine 2, 2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors","volume":"32","author":"Pustenko","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0850","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14756366.2019.1695795","article-title":"Aryl derivatives of 3H\u20131, 2-benzoxathiepine 2, 2-dioxide as carbonic anhydrase inhibitors","volume":"35","author":"Pustenko","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105920_b0855","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/14756366.2020.1722658","article-title":"7-Acylamino-3H-1, 2-benzoxathiepine 2, 2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors","volume":"35","author":"Pustenko","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112300","article-title":"Development of oxathiino [6, 5-b] pyridine 2, 2-dioxide derivatives as selective inhibitors of tumor-related carbonic anhydrases IX and XII","volume":"200","author":"Grand\u0101ne","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2022.105920_b0865","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1021\/acs.jmedchem.7b00766","article-title":"3-Hydroxy-1 H-quinazoline-2, 4-dione as a new scaffold to develop potent and selective inhibitors of the tumor-associated carbonic anhydrases IX and XII","volume":"60","author":"Falsini","year":"2017","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2022.105920_b0870","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.bmc.2016.04.061","article-title":"Pyrazolylbenzo [d] imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII","volume":"24","author":"Kumar","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0875","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3390\/ijms20092354","article-title":"Indole-based hydrazones containing a sulfonamide moiety as selective inhibitors of tumor-associated human carbonic anhydrase isoforms IX and XII","volume":"20","author":"Demir-Yaz\u0131c\u0131","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2022.105920_b0880","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bioorg.2018.07.027","article-title":"Synthesis of novel isoindoline-1, 3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX","volume":"80","author":"Alaa","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0885","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1016\/j.bmc.2013.07.044","article-title":"Carbonic anhydrase inhibitors: Synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4, 5, 6, 7-tetrabromophthalimide moiety","volume":"21","author":"Sethi","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0890","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/14756366.2019.1697250","article-title":"Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation","volume":"35","author":"Abdelrahman","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105920_b0895","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejmech.2015.04.033","article-title":"Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives","volume":"96","author":"Awadallah","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2022.105920_b0900","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/jm501314c","article-title":"Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups","volume":"57","author":"Bozdag","year":"2014","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2022.105920_b0905","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.bmc.2016.04.052","article-title":"Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII","volume":"24","author":"Chandak","year":"2016","journal-title":"Bioorg. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682200325X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682200325X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:36:31Z","timestamp":1758616591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682200325X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":181,"alternative-id":["S004520682200325X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105920","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105920"}}